Literature DB >> 33489398

Plasmablastic Lymphoma Associated with Adjacent Mature Plasma Cell Population Exhibiting Opposite Light Chain Restriction.

Karina Furlan1, Ira Miller1, Brett Mahon1, Fernando A Ocampo Gonzalez1, Nicholas Ward1.   

Abstract

Plasmablastic lymphoma (PBL) is an aggressive high-grade B cell lymphoma, considered a variant of diffuse large B cell lymphoma with approximately 75% mortality within 6-7 months. We describe an unusual case of PBL arising as a maxillary mass in an HIV-negative, nontransplanted 78-year-old female. Histologic examination revealed a diffuse infiltrate of anaplastic appearing cells exhibiting plasmablastic morphology with an adjacent contiguous infiltrate of mature appearing plasma cells. The PBL and mature plasma cell components both demonstrated an immunophenotype of CD20(-), CD38(+), and CD138(+). The two populations differed by the PBL featuring a high proliferation rate by Ki-67 (~95%) with coexpression of both c-MYC and EBV, while the mature plasma cell component featured a low proliferation rate by Ki-67 (~5%) without coexpression of c-MYC or EBV. Kappa/lambda staining demonstrated lambda light chain restriction involving the PBL, while the mature plasma cell infiltrate revealed kappa light chain restriction. Our findings describe the rare association of PBL with a synchronous distinct population of mature plasma cells exhibiting opposite light chain restriction.
Copyright © 2020 Karina Furlan et al.

Entities:  

Year:  2020        PMID: 33489398      PMCID: PMC7803171          DOI: 10.1155/2020/8875547

Source DB:  PubMed          Journal:  Case Rep Pathol        ISSN: 2090-679X


  17 in total

1.  LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism.

Authors:  Peter Cartwright; Cameron McLean; Allan Sheppard; Duane Rivett; Karen Jones; Stephen Dalton
Journal:  Development       Date:  2005-01-26       Impact factor: 6.868

2.  Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm.

Authors:  Henry Y Dong; David T Scadden; Laurence de Leval; Zuoqin Tang; Peter G Isaacson; Nancy L Harris
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

3.  Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.

Authors:  J Chapman; A J Gentles; V Sujoy; F Vega; C I Dumur; T L Blevins; L Bernal-Mizrachi; M Mosunjac; A Pimentel; D Zhu; I S Lossos
Journal:  Leukemia       Date:  2015-04-24       Impact factor: 11.528

4.  Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma.

Authors:  Xin Qing; Nora Sun; Elena Chang; Samuel French; Ping Ji; Changjun Yue
Journal:  Exp Mol Pathol       Date:  2010-10-19       Impact factor: 3.362

5.  Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.

Authors:  H J Delecluse; I Anagnostopoulos; F Dallenbach; M Hummel; T Marafioti; U Schneider; D Huhn; A Schmidt-Westhausen; P A Reichart; U Gross; H Stein
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

6.  Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.

Authors:  Santiago Montes-Moreno; Ana-Rosa Gonzalez-Medina; Socorro-María Rodriguez-Pinilla; Lorena Maestre; Lydia Sanchez-Verde; Giovanna Roncador; Manuela Mollejo; Juan F García; Javier Menarguez; Carlos Montalbán; M Carmen Ruiz-Marcellan; Eulogio Conde; Miguel A Piris
Journal:  Haematologica       Date:  2010-04-23       Impact factor: 9.941

7.  ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.

Authors:  Alexandra Valera; Lluis Colomo; Antonio Martínez; Daphne de Jong; Olga Balagué; Gabriel Matheu; Mónica Martínez; Lekidelu Taddesse-Heath; Elaine S Jaffe; Carlos E Bacchi; Elías Campo
Journal:  Mod Pathol       Date:  2013-04-19       Impact factor: 7.842

Review 8.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

9.  Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Authors:  Lluís Colomo; Florence Loong; Susana Rives; Stefania Pittaluga; Antonio Martínez; Armando López-Guillermo; Jesús Ojanguren; Vicens Romagosa; Elaine S Jaffe; Elías Campo
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

10.  STAT3 is required for the gp130-mediated full activation of the c-myc gene.

Authors:  N Kiuchi; K Nakajima; M Ichiba; T Fukada; M Narimatsu; K Mizuno; M Hibi; T Hirano
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

View more
  1 in total

1.  Plasmablastic lymphoma of the rectum: case report of a rare location and literature review.

Authors:  Razan Saleh AlMohamedi; Waleed AlRajban; Ammar AlRikabi; Maha Arafah
Journal:  J Surg Case Rep       Date:  2022-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.